Early drug development predictions of glass-forming ability and physical stability of drugs
The purpose of this study was to investigate if rapidly measured physical properties can predict glass-forming ability and glass stability of drug compounds. A series of 50 structurally diverse drug molecules were studied with respect to glass-forming ability and, for glass-formers (n=24), the physi...
Saved in:
Published in: | European journal of pharmaceutical sciences Vol. 49; no. 2; pp. 323 - 332 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
Elsevier B.V
13-05-2013
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The purpose of this study was to investigate if rapidly measured physical properties can predict glass-forming ability and glass stability of drug compounds. A series of 50 structurally diverse drug molecules were studied with respect to glass-forming ability and, for glass-formers (n=24), the physical stability upon 1month of storage was determined. Spray-drying and melt-cooling were used to produce the amorphous material and the solid state was analysed by Differential Scanning Calorimetry (DSC) and Powder X-ray Diffraction. Thermal properties and molecular weight (Mw) were used to develop predictive models of (i) glass-forming ability and (ii) physical stability. In total, the glass-forming ability was correctly predicted for 90% of the drugs from their Mw alone. As a rule of thumb, drugs with Mw greater than 300g/mole are expected to be transformed to its amorphous state by using standard process technology. Glass transition temperature and Mw predicted the physical stability upon storage correctly for 78% of the glass-forming compounds. A strong sigmoidal relationship (R2 of 0.96) was identified between crystallization temperature and stability. These findings have the potential to rationalize decisions schemes for utilizing and developing amorphous formulations, through early predictions of glass-forming ability from Mw and physical stability from simple DSC characterization. |
---|---|
AbstractList | The purpose of this study was to investigate if rapidly measured physical properties can predict glass-forming ability and glass stability of drug compounds. A series of 50 structurally diverse drug molecules were studied with respect to glass-forming ability and, for glass-formers (n=24), the physical stability upon 1 month of storage was determined. Spray-drying and melt-cooling were used to produce the amorphous material and the solid state was analysed by Differential Scanning Calorimetry (DSC) and Powder X-ray Diffraction. Thermal properties and molecular weight (Mw) were used to develop predictive models of (i) glass-forming ability and (ii) physical stability. In total, the glass-forming ability was correctly predicted for 90% of the drugs from their Mw alone. As a rule of thumb, drugs with Mw greater than 300 g/mole are expected to be transformed to its amorphous state by using standard process technology. Glass transition temperature and Mw predicted the physical stability upon storage correctly for 78% of the glass-forming compounds. A strong sigmoidal relationship (R(2) of 0.96) was identified between crystallization temperature and stability. These findings have the potential to rationalize decisions schemes for utilizing and developing amorphous formulations, through early predictions of glass-forming ability from Mw and physical stability from simple DSC characterization. The purpose of this study was to investigate if rapidly measured physical properties can predict glass-forming ability and glass stability of drug compounds. A series of 50 structurally diverse drug molecules were studied with respect to glass-forming ability and, for glass-formers (n=24), the physical stability upon 1month of storage was determined. Spray-drying and melt-cooling were used to produce the amorphous material and the solid state was analysed by Differential Scanning Calorimetry (DSC) and Powder X-ray Diffraction. Thermal properties and molecular weight (Mw) were used to develop predictive models of (i) glass-forming ability and (ii) physical stability. In total, the glass-forming ability was correctly predicted for 90% of the drugs from their Mw alone. As a rule of thumb, drugs with Mw greater than 300g/mole are expected to be transformed to its amorphous state by using standard process technology. Glass transition temperature and Mw predicted the physical stability upon storage correctly for 78% of the glass-forming compounds. A strong sigmoidal relationship (R2 of 0.96) was identified between crystallization temperature and stability. These findings have the potential to rationalize decisions schemes for utilizing and developing amorphous formulations, through early predictions of glass-forming ability from Mw and physical stability from simple DSC characterization. |
Author | Bergström, Christel A.S. Mahlin, Denny |
Author_xml | – sequence: 1 givenname: Denny surname: Mahlin fullname: Mahlin, Denny email: denny.mahlin@farmaci.uu.se organization: Department of Pharmacy, Uppsala University, Uppsala, Sweden – sequence: 2 givenname: Christel A.S. surname: Bergström fullname: Bergström, Christel A.S. organization: Department of Pharmacy, Uppsala University, Uppsala, Sweden |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23557841$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-204132$$DView record from Swedish Publication Index |
BookMark | eNp9kcFu1DAQhi1URLeFF-CAfORAlrGdOLbEpSqlRarEBbhwsBx7sniVxMFOivbt8WrbHpFGGmn0zXf4_wtyNsUJCXnLYMuAyY_7Le7nvOXAxBbKMPmCbJhqdQUthzOyAc1VBVq15-Qi5z0ASNXCK3LORdO0qmYb8uvGpuFAfVp31OMDDnEecVronNAHt4Q4ZRp7uhtszlUf0ximHbVdGMJyoHbydP59yMHZgebl6Vz4oy-_Ji97O2R887gvyY8vN9-v76r7b7dfr6_uK9eAWCrdM933Wsu688zL2vuuF762tQLBOetZI5X1THWtZ-A8b7V3jZSiUcCsbFBckg8nb_6L89qZOYXRpoOJNpjP4eeViWln1tVwqJngBX9_wucU_6yYFzOG7HAY7IRxzYaJWpfk2loUlJ9Ql2LOCftnNwNz7MDszbEDc-zAQBkmy9O7R__ajeifX55CL8CnE4AllIeAyWQXcHIl8YRuMT6G__n_AR51mtM |
CitedBy_id | crossref_primary_10_1016_j_ejps_2021_105860 crossref_primary_10_1016_j_xphs_2018_11_006 crossref_primary_10_1146_annurev_chembioeng_060718_030304 crossref_primary_10_3390_pharmaceutics11090425 crossref_primary_10_1021_acs_molpharmaceut_8b00725 crossref_primary_10_1016_j_ejps_2019_105091 crossref_primary_10_1016_j_jsps_2019_03_004 crossref_primary_10_1021_mp4004145 crossref_primary_10_1016_j_jconrel_2023_01_019 crossref_primary_10_1016_j_xphs_2017_10_003 crossref_primary_10_1016_j_ijpharm_2023_123536 crossref_primary_10_1002_jps_24541 crossref_primary_10_1021_acs_molpharmaceut_5b00409 crossref_primary_10_1016_j_addr_2022_114468 crossref_primary_10_3390_molecules29112609 crossref_primary_10_3390_pharmaceutics10020060 crossref_primary_10_1021_acs_molpharmaceut_8b01229 crossref_primary_10_1002_cptc_202200134 crossref_primary_10_1021_acs_molpharmaceut_8b00699 crossref_primary_10_1039_C9ME00109C crossref_primary_10_1007_s11095_017_2174_7 crossref_primary_10_1080_14787210_2019_1675508 crossref_primary_10_1016_j_xphs_2016_07_031 crossref_primary_10_1016_j_ijpharm_2020_119489 crossref_primary_10_1016_j_xphs_2016_03_014 crossref_primary_10_1111_jphp_12984 crossref_primary_10_1080_10837450_2019_1616208 crossref_primary_10_1007_s11095_018_2408_3 crossref_primary_10_1016_j_ejpb_2020_04_017 crossref_primary_10_1016_j_ijpharm_2015_08_101 crossref_primary_10_1016_j_jddst_2019_02_019 crossref_primary_10_1021_acs_molpharmaceut_6b00650 crossref_primary_10_1016_j_xphs_2017_06_012 crossref_primary_10_1021_acs_molpharmaceut_8b00021 crossref_primary_10_4155_tde_15_45 crossref_primary_10_1016_j_ijpharm_2021_120492 crossref_primary_10_3390_pharmaceutics13111926 crossref_primary_10_4155_tde_14_39 crossref_primary_10_1016_j_xphs_2020_08_008 crossref_primary_10_3390_pharmaceutics11060268 crossref_primary_10_1016_j_apt_2018_04_002 crossref_primary_10_3109_03639045_2016_1160105 crossref_primary_10_1016_j_ijpharm_2021_120649 crossref_primary_10_1021_acs_molpharmaceut_5b00351 crossref_primary_10_1021_mp500303a crossref_primary_10_1016_j_ejpb_2018_01_013 crossref_primary_10_1016_j_xphs_2018_03_029 crossref_primary_10_1021_acs_cgd_0c00770 crossref_primary_10_1007_s10953_015_0410_5 crossref_primary_10_1016_j_xphs_2017_03_029 crossref_primary_10_3390_pharmaceutics12121209 crossref_primary_10_1063_5_0156222 crossref_primary_10_1080_17425247_2017_1321634 crossref_primary_10_1016_j_addr_2017_03_002 crossref_primary_10_1016_j_jddst_2023_104290 crossref_primary_10_3109_03639045_2015_1075033 crossref_primary_10_3390_ph13080182 crossref_primary_10_1016_j_jsps_2016_09_013 crossref_primary_10_1016_j_ejpb_2018_11_016 crossref_primary_10_1021_ci5004834 crossref_primary_10_1039_D0CE00070A crossref_primary_10_1016_j_addr_2016_02_005 crossref_primary_10_1016_j_ejps_2024_106780 crossref_primary_10_1155_2022_5916013 crossref_primary_10_1016_j_xphs_2022_11_004 crossref_primary_10_3109_10717544_2014_993747 crossref_primary_10_1016_j_xphs_2016_05_024 crossref_primary_10_1021_acsomega_2c08146 crossref_primary_10_1016_j_ijpharm_2018_09_059 crossref_primary_10_1016_j_ejps_2013_10_015 crossref_primary_10_1021_acs_nanolett_2c01608 crossref_primary_10_1016_j_ijpharm_2020_119545 crossref_primary_10_1063_1_4947476 crossref_primary_10_1021_acs_cgd_1c00997 crossref_primary_10_1021_acs_molpharmaceut_5b00688 crossref_primary_10_1021_acs_molpharmaceut_2c00339 crossref_primary_10_1021_acs_joc_0c01014 crossref_primary_10_1016_j_ejps_2015_08_006 crossref_primary_10_1016_j_xphs_2015_10_008 crossref_primary_10_1039_C9RA08441J crossref_primary_10_14356_kona_2025008 crossref_primary_10_3390_pharmaceutics11050202 crossref_primary_10_1016_j_ijpharm_2022_121784 crossref_primary_10_1039_D1CE01327K crossref_primary_10_1016_j_xphs_2018_04_028 crossref_primary_10_1021_acs_molpharmaceut_0c00355 crossref_primary_10_3390_pharmaceutics11100529 crossref_primary_10_1016_j_xphs_2017_09_024 crossref_primary_10_1021_acs_molpharmaceut_1c00783 |
Cites_doi | 10.1002/jps.21162 10.1023/A:1007516718048 10.1016/j.ijpharm.2011.08.032 10.1016/j.ijpharm.2009.12.009 10.1021/jp110975y 10.1016/0378-5173(92)90137-Q 10.1063/1.3216109 10.1063/1.3586805 10.1016/0001-6160(79)90076-2 10.1007/s11095-010-0129-3 10.1002/jps.22232 10.1023/A:1016292416526 10.1016/j.ijpharm.2012.04.066 10.1016/j.ejpb.2008.07.010 10.1002/jps.21138 10.1002/jps.22214 10.1016/j.ejps.2009.04.005 10.1002/jps.21728 10.1016/j.ejps.2007.06.005 10.1021/jp0700027 10.1023/B:PHAM.0000033003.17251.c3 10.1002/jps.1033 10.1021/cr60135a002 10.1021/mp100339c 10.1002/jps.22197 10.1021/mp3000698 10.1016/j.ijpharm.2004.01.005 10.1021/js9601896 10.1002/jps.10169 10.1007/s11095-006-9047-9 10.1002/jps.21647 10.1007/s11095-006-9023-4 10.1021/la052367t 10.1080/00107516908204405 10.1021/jp7113384 10.1007/s11095-010-0269-5 |
ContentType | Journal Article |
Copyright | 2013 Elsevier B.V. Copyright © 2013 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2013 Elsevier B.V. – notice: Copyright © 2013 Elsevier B.V. All rights reserved. |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 ACNBI ADTPV AOWAS D8T DF2 ZZAVC |
DOI | 10.1016/j.ejps.2013.03.016 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic SWEPUB Uppsala universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Uppsala universitet SwePub Articles full text |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1879-0720 |
EndPage | 332 |
ExternalDocumentID | oai_DiVA_org_uu_204132 10_1016_j_ejps_2013_03_016 23557841 S0928098713001243 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 6I. 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAFTH AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AATCM AAXUO ABFRF ABJNI ABLJU ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA GROUPED_DOAJ IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPCBC SSP SSZ T5K TEORI ~G- AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM 29G AAQXK AAYXX ABFNM ADMUD ADVLN ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB G-2 HMT HVGLF HZ~ OK1 R2- SEW SPT WUQ 7X8 0SF ACNBI ADTPV AOWAS D8T DF2 ZZAVC |
ID | FETCH-LOGICAL-c503t-9f19ff9964bd1d64ddbf3d4a4803221f1568ad18b7d10cd279dc56635801a65e3 |
ISSN | 0928-0987 1879-0720 |
IngestDate | Tue Oct 01 22:14:21 EDT 2024 Fri Oct 25 03:52:12 EDT 2024 Thu Nov 21 22:31:26 EST 2024 Sat Sep 28 08:01:38 EDT 2024 Fri Feb 23 02:19:36 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Amorphous stability Glass-forming ability Glass transition temperature Molecular weight Prediction Crystallization temperature |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/3.0 Copyright © 2013 Elsevier B.V. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c503t-9f19ff9964bd1d64ddbf3d4a4803221f1568ad18b7d10cd279dc56635801a65e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-204132 |
PMID | 23557841 |
PQID | 1349092743 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | swepub_primary_oai_DiVA_org_uu_204132 proquest_miscellaneous_1349092743 crossref_primary_10_1016_j_ejps_2013_03_016 pubmed_primary_23557841 elsevier_sciencedirect_doi_10_1016_j_ejps_2013_03_016 |
PublicationCentury | 2000 |
PublicationDate | 2013-05-13 |
PublicationDateYYYYMMDD | 2013-05-13 |
PublicationDate_xml | – month: 05 year: 2013 text: 2013-05-13 day: 13 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | European journal of pharmaceutical sciences |
PublicationTitleAlternate | Eur J Pharm Sci |
PublicationYear | 2013 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Kearns, Swallen, Ediger, Wu, Sun, Yu (b0080) 2008; 112 Stukalin, Douglas, Freed (b0195) 2009; 131 Bhugra, Pikal (b0025) 2008; 97 Lindfors, Forssen, Skantze, Skantze, Zackrisson, Olsson (b0095) 2006; 22 Hancock, Shamblin, Zografi (b0065) 1995; 12 Branchu, Roqueda, Plumb, Cook (b0035) 2007; 32 Hancock, Parks (b0055) 2000; 17 Laitinen, R., Löbmann, K., Strachan, C.J., Grohganz, H., Rades, T., 2012. Emerging trends in the stabilization of amorphous drugs. International Journal of Pharmaceutics, in press. Xiang, Anderson (b0170) 2013; 10 Ziffels, Steckel (b0190) 2010; 387 Thompson, Spaepen (b0140) 1979; 27 Zhou, Zhang, Law, Grant, Schmitt (b0185) 2002; 91 Bhugra, Shmeis, Krill, Pikal (b0030) 2008; 97 Turnbull (b0150) 1969; 10 Aso, Yoshioka, Kojima (b0005) 2001; 90 Bhattacharya, Suryanarayanan (b0015) 2009; 98 Surana, Pyne, Suryanarayanan (b0135) 2004; 21 Baird, Van Eerdenbrugh, Taylor (b0010) 2010; 99 Wu, Yu (b0165) 2006; V23 Yamaguchi, Nishimura, Okamoto, Takeuchi, Yamamoto (b0175) 1992; 85 Murdande, Pikal, Shanker, Bogner (b0110) 2010; 27 Schoug, Mahlin, Jonson, Håkansson (b0120) 2009; 99 Kauzmann (b0070) 1948; 43 Singh, de Pablo (b0125) 2011; 134 Mahlin, Ponnambalam, Heidarian Höckerfelt, Bergström (b0100) 2011; 8 Trasi, Boerrigter, Byrn (b0145) 2010; 27 Hancock, Zograf (b0060) 1997; 86 Corrigan, Corrigan, Healy (b0045) 2004; 273 Lin, Cogdill, Wildfong (b0090) 2009; 98 Vyazovkin, Dranca (b0160) 2007; 111 Graeser, Patterson, Zeitler, Gordon, Rades (b0050) 2009; 37 Ping, Paraska, Baker, Harrowell, Angell (b0115) 2011; 115 Kawabata, Wada, Nakatani, Yamada, Onoue (b0075) 2011; 420 Van Eerdenbrugh, Baird, Taylor (b0155) 2010; 99 Zhang, Aaltonen, Tian, Saville, Rades (b0180) 2009; 71 Marsac, Konno, Taylor (b0105) 2006; 23 Caron, Bhugra, Pikal (b0040) 2010; 99 Singh (10.1016/j.ejps.2013.03.016_b0125) 2011; 134 Baird (10.1016/j.ejps.2013.03.016_b0010) 2010; 99 Wu (10.1016/j.ejps.2013.03.016_b0165) 2006; V23 Hancock (10.1016/j.ejps.2013.03.016_b0065) 1995; 12 10.1016/j.ejps.2013.03.016_b0085 Branchu (10.1016/j.ejps.2013.03.016_b0035) 2007; 32 Hancock (10.1016/j.ejps.2013.03.016_b0060) 1997; 86 Mahlin (10.1016/j.ejps.2013.03.016_b0100) 2011; 8 Kawabata (10.1016/j.ejps.2013.03.016_b0075) 2011; 420 Ping (10.1016/j.ejps.2013.03.016_b0115) 2011; 115 Bhugra (10.1016/j.ejps.2013.03.016_b0030) 2008; 97 Trasi (10.1016/j.ejps.2013.03.016_b0145) 2010; 27 Van Eerdenbrugh (10.1016/j.ejps.2013.03.016_b0155) 2010; 99 Murdande (10.1016/j.ejps.2013.03.016_b0110) 2010; 27 Turnbull (10.1016/j.ejps.2013.03.016_b0150) 1969; 10 Xiang (10.1016/j.ejps.2013.03.016_b0170) 2013; 10 Thompson (10.1016/j.ejps.2013.03.016_b0140) 1979; 27 Kearns (10.1016/j.ejps.2013.03.016_b0080) 2008; 112 Surana (10.1016/j.ejps.2013.03.016_b0135) 2004; 21 Zhang (10.1016/j.ejps.2013.03.016_b0180) 2009; 71 Lin (10.1016/j.ejps.2013.03.016_b0090) 2009; 98 Kauzmann (10.1016/j.ejps.2013.03.016_b0070) 1948; 43 Graeser (10.1016/j.ejps.2013.03.016_b0050) 2009; 37 Hancock (10.1016/j.ejps.2013.03.016_b0055) 2000; 17 Vyazovkin (10.1016/j.ejps.2013.03.016_b0160) 2007; 111 Bhattacharya (10.1016/j.ejps.2013.03.016_b0015) 2009; 98 Aso (10.1016/j.ejps.2013.03.016_b0005) 2001; 90 Lindfors (10.1016/j.ejps.2013.03.016_b0095) 2006; 22 Marsac (10.1016/j.ejps.2013.03.016_b0105) 2006; 23 Stukalin (10.1016/j.ejps.2013.03.016_b0195) 2009; 131 Yamaguchi (10.1016/j.ejps.2013.03.016_b0175) 1992; 85 Corrigan (10.1016/j.ejps.2013.03.016_b0045) 2004; 273 Schoug (10.1016/j.ejps.2013.03.016_b0120) 2009; 99 Bhugra (10.1016/j.ejps.2013.03.016_b0025) 2008; 97 Caron (10.1016/j.ejps.2013.03.016_b0040) 2010; 99 Zhou (10.1016/j.ejps.2013.03.016_b0185) 2002; 91 Ziffels (10.1016/j.ejps.2013.03.016_b0190) 2010; 387 |
References_xml | – volume: 90 start-page: 798 year: 2001 end-page: 806 ident: b0005 article-title: Explanation of the crystallization rate of amorphous nifedipine and phenobarbital from their molecular mobility as measured by C-13 nuclear magnetic resonance relaxation time and the relaxation time obtained from the heating rate dependence of the glass transition temperature publication-title: Journal of Pharmaceutical Sciences contributor: fullname: Kojima – volume: 8 start-page: 498 year: 2011 end-page: 506 ident: b0100 article-title: Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development publication-title: Molecular Pharmaceutics contributor: fullname: Bergström – volume: 131 start-page: 114905 year: 2009 ident: b0195 article-title: Application of the entropy theory of glass formation to poly(alpha-olefins) publication-title: Journal of Chemical Physics contributor: fullname: Freed – volume: 98 start-page: 2935 year: 2009 end-page: 2953 ident: b0015 article-title: Local mobility in amorphous pharmaceuticals–characterization and implications on stability publication-title: Journal of Pharmaceutical Sciences contributor: fullname: Suryanarayanan – volume: 97 start-page: 1329 year: 2008 end-page: 1349 ident: b0025 article-title: Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state publication-title: Journal of Pharmaceutical Sciences contributor: fullname: Pikal – volume: 97 start-page: 455 year: 2008 end-page: 472 ident: b0030 article-title: Prediction of onset of crystallization from experimental relaxation times. II. Comparison between predicted and experimental onset times publication-title: Journal of Pharmaceutical Sciences contributor: fullname: Pikal – volume: 23 start-page: 2306 year: 2006 end-page: 2316 ident: b0105 article-title: A comparison of the physical stability of amorphous felodipine and nifedipine systems publication-title: Pharmaceutical Research contributor: fullname: Taylor – volume: 10 start-page: 102 year: 2013 end-page: 114 ident: b0170 article-title: Molecular dynamics simulation of amorphous indomethacin publication-title: Molecular Pharmaceutics contributor: fullname: Anderson – volume: 111 start-page: 7283 year: 2007 end-page: 7287 ident: b0160 article-title: Effect of physical aging on nucleation of amorphous indomethacin publication-title: Journal of Physical Chemistry B contributor: fullname: Dranca – volume: 32 start-page: 128 year: 2007 end-page: 139 ident: b0035 article-title: A decision-support tool for the formulation of orally active, poorly soluble compounds publication-title: European Journal of Pharmaceutical Sciences contributor: fullname: Cook – volume: V23 start-page: 2350 year: 2006 end-page: 2355 ident: b0165 article-title: Surface crystallization of indomethacin below Tg publication-title: Pharmaceutical Research contributor: fullname: Yu – volume: 91 start-page: 1863 year: 2002 end-page: 1872 ident: b0185 article-title: Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility publication-title: Journal of Pharmaceutical Sciences contributor: fullname: Schmitt – volume: 17 start-page: 397 year: 2000 end-page: 404 ident: b0055 article-title: What is the true solubility advantage for amorphous pharmaceuticals? publication-title: Pharmaceutical Research contributor: fullname: Parks – volume: 27 start-page: 1377 year: 2010 end-page: 1389 ident: b0145 article-title: Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin publication-title: Pharmaceutical Research contributor: fullname: Byrn – volume: 27 start-page: 1855 year: 1979 end-page: 1859 ident: b0140 article-title: On the approximation of the free energy change on crystallization publication-title: Acta Metallurgica contributor: fullname: Spaepen – volume: 99 start-page: 3826 year: 2010 end-page: 3838 ident: b0155 article-title: Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation–classification and comparison with crystallization tendency from undercooled melts publication-title: Journal of Pharmaceutical Sciences contributor: fullname: Taylor – volume: 420 start-page: 1 year: 2011 end-page: 10 ident: b0075 article-title: Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications publication-title: International Journal of Pharmaceutics contributor: fullname: Onoue – volume: 22 start-page: 911 year: 2006 end-page: 916 ident: b0095 article-title: Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations publication-title: Langmuir contributor: fullname: Olsson – volume: 10 start-page: 473 year: 1969 end-page: 488 ident: b0150 article-title: Under what conditions can a glass be formed? publication-title: Contemporary Physics contributor: fullname: Turnbull – volume: 12 start-page: 799 year: 1995 end-page: 806 ident: b0065 article-title: Molecular mobility of amorphous pharmaceutical solids below their glass-transition temperatures publication-title: Pharmaceutical Research contributor: fullname: Zografi – volume: 21 start-page: 1167 year: 2004 end-page: 1176 ident: b0135 article-title: Effect of preparation method on physical properties of amorphous trehalose publication-title: Pharmaceutical Research contributor: fullname: Suryanarayanan – volume: 134 start-page: 194903 year: 2011 end-page: 194907 ident: b0125 article-title: A molecular view of vapor deposited glasses publication-title: The Journal of Chemical Physics contributor: fullname: de Pablo – volume: 112 start-page: 4934 year: 2008 end-page: 4942 ident: b0080 article-title: Hiking down the energy landscape: progress toward the Kauzmann temperature via vapor deposition publication-title: Journal of Physical Chemistry B contributor: fullname: Yu – volume: 99 start-page: 2032 year: 2009 end-page: 2048 ident: b0120 article-title: Differential effects of polymers PVP90 and Ficoll400 on storage stability and viability of publication-title: Journal of Applied Microbiology contributor: fullname: Håkansson – volume: 71 start-page: 64 year: 2009 end-page: 70 ident: b0180 article-title: Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin publication-title: European Journal of Pharmaceutics and Biopharmaceutics contributor: fullname: Rades – volume: 86 start-page: 1 year: 1997 end-page: 12 ident: b0060 article-title: Characteristics and significance of the amorphous state in pharmaceutical systems publication-title: Journal of Pharmaceutical Sciences contributor: fullname: Zograf – volume: 98 start-page: 2696 year: 2009 end-page: 2708 ident: b0090 article-title: Informatic calibration of a materials properties database for predictive assessment of mechanically activated disordering potential for small molecule organic solids publication-title: Journal of Pharmaceutical Sciences contributor: fullname: Wildfong – volume: 27 start-page: 2704 year: 2010 end-page: 2714 ident: b0110 article-title: Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals publication-title: Pharmaceutical Research contributor: fullname: Bogner – volume: 115 start-page: 4696 year: 2011 end-page: 4702 ident: b0115 article-title: Molecular engineering of the glass transition: glass-forming ability across a homologous series of cyclic stilbenes publication-title: The Journal of Physical Chemistry B contributor: fullname: Angell – volume: 273 start-page: 171 year: 2004 end-page: 182 ident: b0045 article-title: Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systems publication-title: International Journal of Pharmaceutics contributor: fullname: Healy – volume: 85 start-page: 87 year: 1992 end-page: 96 ident: b0175 article-title: Glass-formation of 4′′-O-(4-methoxyphenyl)acetyltylosin and physicochemical stability of the amorphous solid publication-title: International Journal of Pharmaceutics contributor: fullname: Yamamoto – volume: 99 start-page: 3787 year: 2010 end-page: 3806 ident: b0010 article-title: A classification system to assess the crystallization tendency of organic molecules from undercooled melts publication-title: Journal of Pharmaceutical Sciences contributor: fullname: Taylor – volume: 37 start-page: 492 year: 2009 end-page: 498 ident: b0050 article-title: Correlating thermodynamic and kinetic parameters with amorphous stability publication-title: European Journal of Pharmaceutical Sciences contributor: fullname: Rades – volume: 99 start-page: 3887 year: 2010 end-page: 3900 ident: b0040 article-title: Prediction of onset of crystallization in amorphous pharmaceutical systems: phenobarbital, nifedipine/PVP, and phenobarbital/PVP publication-title: Journal of Pharmaceutical Sciences contributor: fullname: Pikal – volume: 387 start-page: 71 year: 2010 end-page: 78 ident: b0190 article-title: Influence of amorphous content on compaction behaviour of anhydrous [alpha]-lactose publication-title: International Journal of Pharmaceutics contributor: fullname: Steckel – volume: 43 start-page: 219 year: 1948 end-page: 256 ident: b0070 article-title: The nature of the glassy state and the behavior of liquids at low temperatures publication-title: Chemical Reviews contributor: fullname: Kauzmann – volume: 97 start-page: 455 year: 2008 ident: 10.1016/j.ejps.2013.03.016_b0030 article-title: Prediction of onset of crystallization from experimental relaxation times. II. Comparison between predicted and experimental onset times publication-title: Journal of Pharmaceutical Sciences doi: 10.1002/jps.21162 contributor: fullname: Bhugra – volume: 17 start-page: 397 year: 2000 ident: 10.1016/j.ejps.2013.03.016_b0055 article-title: What is the true solubility advantage for amorphous pharmaceuticals? publication-title: Pharmaceutical Research doi: 10.1023/A:1007516718048 contributor: fullname: Hancock – volume: 420 start-page: 1 year: 2011 ident: 10.1016/j.ejps.2013.03.016_b0075 article-title: Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications publication-title: International Journal of Pharmaceutics doi: 10.1016/j.ijpharm.2011.08.032 contributor: fullname: Kawabata – volume: 387 start-page: 71 year: 2010 ident: 10.1016/j.ejps.2013.03.016_b0190 article-title: Influence of amorphous content on compaction behaviour of anhydrous [alpha]-lactose publication-title: International Journal of Pharmaceutics doi: 10.1016/j.ijpharm.2009.12.009 contributor: fullname: Ziffels – volume: 115 start-page: 4696 year: 2011 ident: 10.1016/j.ejps.2013.03.016_b0115 article-title: Molecular engineering of the glass transition: glass-forming ability across a homologous series of cyclic stilbenes publication-title: The Journal of Physical Chemistry B doi: 10.1021/jp110975y contributor: fullname: Ping – volume: 85 start-page: 87 year: 1992 ident: 10.1016/j.ejps.2013.03.016_b0175 article-title: Glass-formation of 4′′-O-(4-methoxyphenyl)acetyltylosin and physicochemical stability of the amorphous solid publication-title: International Journal of Pharmaceutics doi: 10.1016/0378-5173(92)90137-Q contributor: fullname: Yamaguchi – volume: 131 start-page: 114905 year: 2009 ident: 10.1016/j.ejps.2013.03.016_b0195 article-title: Application of the entropy theory of glass formation to poly(alpha-olefins) publication-title: Journal of Chemical Physics doi: 10.1063/1.3216109 contributor: fullname: Stukalin – volume: 134 start-page: 194903 year: 2011 ident: 10.1016/j.ejps.2013.03.016_b0125 article-title: A molecular view of vapor deposited glasses publication-title: The Journal of Chemical Physics doi: 10.1063/1.3586805 contributor: fullname: Singh – volume: 27 start-page: 1855 year: 1979 ident: 10.1016/j.ejps.2013.03.016_b0140 article-title: On the approximation of the free energy change on crystallization publication-title: Acta Metallurgica doi: 10.1016/0001-6160(79)90076-2 contributor: fullname: Thompson – volume: 27 start-page: 1377 year: 2010 ident: 10.1016/j.ejps.2013.03.016_b0145 article-title: Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin publication-title: Pharmaceutical Research doi: 10.1007/s11095-010-0129-3 contributor: fullname: Trasi – volume: 99 start-page: 3887 year: 2010 ident: 10.1016/j.ejps.2013.03.016_b0040 article-title: Prediction of onset of crystallization in amorphous pharmaceutical systems: phenobarbital, nifedipine/PVP, and phenobarbital/PVP publication-title: Journal of Pharmaceutical Sciences doi: 10.1002/jps.22232 contributor: fullname: Caron – volume: 12 start-page: 799 year: 1995 ident: 10.1016/j.ejps.2013.03.016_b0065 article-title: Molecular mobility of amorphous pharmaceutical solids below their glass-transition temperatures publication-title: Pharmaceutical Research doi: 10.1023/A:1016292416526 contributor: fullname: Hancock – ident: 10.1016/j.ejps.2013.03.016_b0085 doi: 10.1016/j.ijpharm.2012.04.066 – volume: 71 start-page: 64 year: 2009 ident: 10.1016/j.ejps.2013.03.016_b0180 article-title: Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin publication-title: European Journal of Pharmaceutics and Biopharmaceutics doi: 10.1016/j.ejpb.2008.07.010 contributor: fullname: Zhang – volume: 97 start-page: 1329 year: 2008 ident: 10.1016/j.ejps.2013.03.016_b0025 article-title: Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state publication-title: Journal of Pharmaceutical Sciences doi: 10.1002/jps.21138 contributor: fullname: Bhugra – volume: 99 start-page: 3826 year: 2010 ident: 10.1016/j.ejps.2013.03.016_b0155 article-title: Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation–classification and comparison with crystallization tendency from undercooled melts publication-title: Journal of Pharmaceutical Sciences doi: 10.1002/jps.22214 contributor: fullname: Van Eerdenbrugh – volume: 37 start-page: 492 year: 2009 ident: 10.1016/j.ejps.2013.03.016_b0050 article-title: Correlating thermodynamic and kinetic parameters with amorphous stability publication-title: European Journal of Pharmaceutical Sciences doi: 10.1016/j.ejps.2009.04.005 contributor: fullname: Graeser – volume: 98 start-page: 2935 year: 2009 ident: 10.1016/j.ejps.2013.03.016_b0015 article-title: Local mobility in amorphous pharmaceuticals–characterization and implications on stability publication-title: Journal of Pharmaceutical Sciences doi: 10.1002/jps.21728 contributor: fullname: Bhattacharya – volume: 32 start-page: 128 year: 2007 ident: 10.1016/j.ejps.2013.03.016_b0035 article-title: A decision-support tool for the formulation of orally active, poorly soluble compounds publication-title: European Journal of Pharmaceutical Sciences doi: 10.1016/j.ejps.2007.06.005 contributor: fullname: Branchu – volume: 111 start-page: 7283 year: 2007 ident: 10.1016/j.ejps.2013.03.016_b0160 article-title: Effect of physical aging on nucleation of amorphous indomethacin publication-title: Journal of Physical Chemistry B doi: 10.1021/jp0700027 contributor: fullname: Vyazovkin – volume: 21 start-page: 1167 year: 2004 ident: 10.1016/j.ejps.2013.03.016_b0135 article-title: Effect of preparation method on physical properties of amorphous trehalose publication-title: Pharmaceutical Research doi: 10.1023/B:PHAM.0000033003.17251.c3 contributor: fullname: Surana – volume: 90 start-page: 798 year: 2001 ident: 10.1016/j.ejps.2013.03.016_b0005 publication-title: Journal of Pharmaceutical Sciences doi: 10.1002/jps.1033 contributor: fullname: Aso – volume: 43 start-page: 219 year: 1948 ident: 10.1016/j.ejps.2013.03.016_b0070 article-title: The nature of the glassy state and the behavior of liquids at low temperatures publication-title: Chemical Reviews doi: 10.1021/cr60135a002 contributor: fullname: Kauzmann – volume: 8 start-page: 498 year: 2011 ident: 10.1016/j.ejps.2013.03.016_b0100 article-title: Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development publication-title: Molecular Pharmaceutics doi: 10.1021/mp100339c contributor: fullname: Mahlin – volume: 99 start-page: 3787 year: 2010 ident: 10.1016/j.ejps.2013.03.016_b0010 article-title: A classification system to assess the crystallization tendency of organic molecules from undercooled melts publication-title: Journal of Pharmaceutical Sciences doi: 10.1002/jps.22197 contributor: fullname: Baird – volume: 10 start-page: 102 year: 2013 ident: 10.1016/j.ejps.2013.03.016_b0170 article-title: Molecular dynamics simulation of amorphous indomethacin publication-title: Molecular Pharmaceutics doi: 10.1021/mp3000698 contributor: fullname: Xiang – volume: 273 start-page: 171 year: 2004 ident: 10.1016/j.ejps.2013.03.016_b0045 article-title: Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systems publication-title: International Journal of Pharmaceutics doi: 10.1016/j.ijpharm.2004.01.005 contributor: fullname: Corrigan – volume: 86 start-page: 1 year: 1997 ident: 10.1016/j.ejps.2013.03.016_b0060 article-title: Characteristics and significance of the amorphous state in pharmaceutical systems publication-title: Journal of Pharmaceutical Sciences doi: 10.1021/js9601896 contributor: fullname: Hancock – volume: 91 start-page: 1863 year: 2002 ident: 10.1016/j.ejps.2013.03.016_b0185 article-title: Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility publication-title: Journal of Pharmaceutical Sciences doi: 10.1002/jps.10169 contributor: fullname: Zhou – volume: 23 start-page: 2306 year: 2006 ident: 10.1016/j.ejps.2013.03.016_b0105 article-title: A comparison of the physical stability of amorphous felodipine and nifedipine systems publication-title: Pharmaceutical Research doi: 10.1007/s11095-006-9047-9 contributor: fullname: Marsac – volume: 99 start-page: 2032 year: 2009 ident: 10.1016/j.ejps.2013.03.016_b0120 article-title: Differential effects of polymers PVP90 and Ficoll400 on storage stability and viability of Lactobacillus coryniformis Si3 freeze-dried in sucrose publication-title: Journal of Applied Microbiology contributor: fullname: Schoug – volume: 98 start-page: 2696 year: 2009 ident: 10.1016/j.ejps.2013.03.016_b0090 article-title: Informatic calibration of a materials properties database for predictive assessment of mechanically activated disordering potential for small molecule organic solids publication-title: Journal of Pharmaceutical Sciences doi: 10.1002/jps.21647 contributor: fullname: Lin – volume: V23 start-page: 2350 year: 2006 ident: 10.1016/j.ejps.2013.03.016_b0165 article-title: Surface crystallization of indomethacin below Tg publication-title: Pharmaceutical Research doi: 10.1007/s11095-006-9023-4 contributor: fullname: Wu – volume: 22 start-page: 911 year: 2006 ident: 10.1016/j.ejps.2013.03.016_b0095 article-title: Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations publication-title: Langmuir doi: 10.1021/la052367t contributor: fullname: Lindfors – volume: 10 start-page: 473 year: 1969 ident: 10.1016/j.ejps.2013.03.016_b0150 article-title: Under what conditions can a glass be formed? publication-title: Contemporary Physics doi: 10.1080/00107516908204405 contributor: fullname: Turnbull – volume: 112 start-page: 4934 year: 2008 ident: 10.1016/j.ejps.2013.03.016_b0080 article-title: Hiking down the energy landscape: progress toward the Kauzmann temperature via vapor deposition publication-title: Journal of Physical Chemistry B doi: 10.1021/jp7113384 contributor: fullname: Kearns – volume: 27 start-page: 2704 year: 2010 ident: 10.1016/j.ejps.2013.03.016_b0110 article-title: Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals publication-title: Pharmaceutical Research doi: 10.1007/s11095-010-0269-5 contributor: fullname: Murdande |
SSID | ssj0006870 |
Score | 2.4345896 |
Snippet | The purpose of this study was to investigate if rapidly measured physical properties can predict glass-forming ability and glass stability of drug compounds. A... |
SourceID | swepub proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 323 |
SubjectTerms | Amorphous stability Calorimetry, Differential Scanning Crystallization temperature Drug Compounding Drug Stability Glass - chemistry Glass transition temperature Glass-forming ability Models, Chemical Molecular weight Pharmaceutical Preparations - chemistry Powder Diffraction Prediction Transition Temperature X-Ray Diffraction |
Title | Early drug development predictions of glass-forming ability and physical stability of drugs |
URI | https://dx.doi.org/10.1016/j.ejps.2013.03.016 https://www.ncbi.nlm.nih.gov/pubmed/23557841 https://search.proquest.com/docview/1349092743 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-204132 |
Volume | 49 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa67YUXxJ0yQEaCvbBUcW5NHwsrGjygSS1oEg-WE9tllUirpHnYv985tnNZqyFAQqqiyk0TN9_Xcz4f-xwT8tb3MyHzJPAkuDMv0lp5kygQXixAbqS5EEJhwO18Pv56mZ7Notlg0CwW7tr-K9LQBlhj5uxfoN1eFBrgPWAOR0Adjn-Eu61YLMt62SREmen-TYkzMu2yNyOaPRSsJknRrJC1lZg2DXAgG10znI_Xq-6M4jtFu_l5Kz7unGsr2nGn5Stn5IqiS6RQ5bLamhn7D8mvruCBAu6M5qN-WIKZRYA2q9TGyvbyZWzQEethT5yLVdbkpmNMowr8vk22ZUwd94KegQ1tdrLz1aGNje65ARuRWI3UaoMl2VloCtmynZrbxovPsU_YJZzXA7ETHpCjAIwW2Myj6efZ5ZfWryep2Xqw_Q0uBcuuFty9010yZ38Ys1Oj1uiaxQNy3w1I6NQy6SEZqOIRObmwUF6f0kWXoFed0hN60dU6v35Mfhi6UaQH7dGN9uhG15reoht1vKJAN9rQjbZ0w_MN3Z6Qb59mi4_nntuvw8tjP9x6E80mWsMAOsokk0kkZaZDGYko9cFtMM3iJBWSpdlYMj-X8JRlHqPiBZUkkliFT8lhsS7Uc0KlHAdhqOIgjzQMKWBckGFgIdRJnOFM8pC8bx4v39iyLLxZr7jiCAZHMLgPL5YMSdwgwB33rWDkQJjffu9NAxcHq4tTaaJQ67riWNQTiADye0ieWRzbfgQg4XE2f0jeWWDbT7CU-9nV9ylfl0te13ArkJDBi3_s3TG51_3xXpLDbVmrV-SgkvVrR90bwr6-4A |
link.rule.ids | 230,315,782,786,887,27933,27934 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early+drug+development+predictions+of+glass-forming+ability+and+physical+stability+of+drugs&rft.jtitle=European+journal+of+pharmaceutical+sciences&rft.au=Mahlin%2C+Denny&rft.au=Bergstr%C3%B6m%2C+Christel+A.S.&rft.date=2013-05-13&rft.pub=Elsevier+B.V&rft.issn=0928-0987&rft.eissn=1879-0720&rft.volume=49&rft.issue=2&rft.spage=323&rft.epage=332&rft_id=info:doi/10.1016%2Fj.ejps.2013.03.016&rft.externalDocID=S0928098713001243 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0928-0987&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0928-0987&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0928-0987&client=summon |